Lecanemab Questions
Congratulations to Dr. Stephen Nadeau on the publication of “Lecanemab Questions,” which appears in the April issue of Neurology. Abstract The recently published results of the 18-month randomized controlled trial of lecanemab, reporting the efficacy of the drug in slowing the progression of early Alzheimer disease, quickly led to approval…